Pinchas Cohen is dean of the Leonard Davis School of Gerontology at the University of Southern California. He pioneered the emerging science of mitochondrial-derived peptides, holds several patents and is a co-founder of CohBar, a biotechnology company developing treatments for diseases of aging. Cohen has received numerous awards for his research, including a National Institute on Aging EUREKA Award and a Transformative R01 Award from the director of the National Institutes of Health. New initiatives that Cohen is leading include the development of a center for digital aging and the creation of tools for "personalized aging," which employs the latest technologies, such as genomics, to individualizing healthy aging strategies. Previously, he was on the faculty of the University of Pennsylvania and the University of California at Los Angeles. Cohen graduated from Technion Medical School in Israel and trained at Stanford University.